Solara Active Pharma Sciences balance sheet

As of Sep 2026

Total assets: ₹2,454cr+7.0% on Sep 2025
Shareholders' equity: ₹1,439cr+14.4% on Sep 2025
Total debt: ₹570cr−8.5% on Sep 2025
Cash and investments: ₹25.1cr+575.2% on Sep 2025

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	765	793	739	858	921
	208	205	280	256	238
	0.0	0.0	2.3	2.4	23.9
	365	365	365	365	365
	15.9	22.2	29.8	42.6	54.4
	1.6	1.6	1.7	1.7	1.7
	16.9	16.7	16.3	15.4	14.5
	18.5	18.4	18.0	17.1	16.2
	0.0	0.0	—	3.6	83.1
	73.3	71.1	69.4	5.3	10.1
	1,445	1,474	1,503	1,550	1,712
	367	318	318	360	558
	0.9	3.0	0.0	0.0	0.0
	506	439	327	349	537
	24.1	4.5	4.0	8.4	8.7
	45.9	45.9	0.2	0.2	0.2
	0.4	0.0	0.0	0.3	32.6
	7.6	6.5	12.4	7.4	13.2
	585	499	343	365	592
	57.0	41.6	67.8	63.5	37.5
	1,009	858	729	788	1,187
	0.0	0.0	—	12.7	0.0
	2,454	2,333	2,232	2,351	2,899
Equity
	48.2	44.5	40.3	36.0	36.0
	1,388	1,208	1,054	898	1,464
	1,436	1,253	1,094	934	1,500
	2.7	2.7	2.7	2.9	2.2
	1,439	1,256	1,097	937	1,502
Liabilities
	178	110	114	106	235
	18.5	19.2	18.2	12.0	11.6
	196	130	132	118	247
	53.6	53.5	9.9	10.1	10.7
	—	—	48.9	43.6	38.4
	250	183	191	172	296
	393	554	662	894	766
	319	274	249	313	306
	13.8	35.7	20.1	13.5	14.5
	725	864	931	1,221	1,086
	14.9	13.9	2.2	2.0	2.1
	0.0	0.0	0.0	0.0	0.0
	26.0	16.4	10.9	20.2	12.4
	766	894	944	1,243	1,101
	—	—	0.0	0.1	0.0
	1,015	1,077	1,135	1,414	1,397
	2,454	2,333	2,232	2,351	2,899
Trade payables — MSME split
	12.9	19.2	38.0	—	—
	306	255	211	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SOLARA₹653.80

Solara Active Pharma Sciences Limited

· Pharma & Health

₹ CrorePeersINDSWFTLAB DCAL SMSPHARMA HIKAL PANACEABIO SAIPARENT INDOCO UNICHEMLABMcap ₹2,910 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	920.6	857.9	738.7	793.2	765.2
+ Capital Work-in-Progress	238.5	256.4	280.1	204.8	207.6
+ Investment Property	23.9	2.4	2.3	0.0	0.0
+ Goodwill	365.1	365.1	364.9	364.9	364.9
+ Other Intangibles	54.4	42.6	29.8	22.2	15.9
+ Non-current Investments	1.7	1.7	1.7	1.6	1.6
+ Other Non-current Financial Assets	14.5	15.4	16.3	16.7	16.9
Non-current Financial Assets	16.2	17.1	18.0	18.4	18.5
+ Deferred Tax Assets	83.1	3.6	—	0.0	0.0
+ Other Non-current Assets	10.1	5.3	69.4	71.1	73.3
Total Non-current Assets	1,711.7	1,550.2	1,503.1	1,474.5	1,445.3
Current Assets
+ Inventories	558.1	359.7	317.9	317.9	366.8
+ Current Investments	0.0	0.0	0.0	3.0	0.9
+ Trade Receivables	537.0	348.5	326.6	438.7	506.1
+ Cash & Cash Equivalents	8.7	8.4	4.0	4.5	24.1
+ Other Bank Balances	0.2	0.2	0.2	45.9	45.9
+ Short-term Loans	32.6	0.3	0.0	0.0	0.4
+ Other Current Financial Assets	13.2	7.4	12.4	6.5	7.6
Current Financial Assets	591.7	364.9	343.1	498.6	585.0
+ Other Current Assets	37.5	63.5	67.8	41.6	57.0
Total Current Assets	1,187.3	788.1	728.7	858.1	1,008.8
+ Assets Held for Sale	0.0	12.7	—	0.0	0.0
Total Assets	2,899.1	2,351.0	2,231.8	2,332.6	2,454.1
Equity
+ Equity Share Capital	36.0	36.0	40.3	44.5	48.2
+ Other Equity / Reserves	1,464.2	897.7	1,054.0	1,208.4	1,387.9
Equity — Owners of Parent	1,500.2	933.7	1,094.2	1,252.9	1,436.1
+ Minority Interest	2.2	2.9	2.7	2.7	2.7
Total Equity	1,502.5	936.6	1,096.9	1,255.6	1,438.8
Liabilities
+ Borrowings — Non-current	235.1	105.8	113.9	110.5	177.5
+ Other Non-current Financial Liab	11.6	12.0	18.2	19.2	18.5
Non-current Financial Liabilities	246.7	117.9	132.1	129.7	196.0
+ Provisions — Non-current	10.7	10.1	9.9	53.5	53.6
+ Other Non-current Liabilities	38.4	43.6	48.9	—	—
Non-current Liabilities	295.7	171.5	190.8	183.1	249.6
+ Borrowings — Current	766.1	894.1	662.2	554.1	392.6
+ Trade Payables	305.9	313.0	248.6	273.9	318.5
+ Other Current Financial Liab	14.5	13.5	20.1	35.7	13.8
Current Financial Liabilities	1,086.4	1,220.6	931.0	863.7	724.9
+ Provisions — Current	2.1	2.0	2.2	13.9	14.9
+ Current Tax Liabilities	0.0	0.0	0.0	0.0	0.0
+ Other Current Liabilities	12.4	20.2	10.9	16.4	26.0
Current Liabilities	1,100.9	1,242.8	944.1	893.9	765.8
+ Liabilities Held for Sale	0.0	0.1	0.0	—	—
Total Liabilities	1,396.6	1,414.4	1,134.9	1,077.0	1,015.4
Total Equity & Liabilities	2,899.1	2,351.0	2,231.8	2,332.6	2,454.1
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	38.0	19.2	12.9
+ Dues to Other Creditors — Current	—	—	210.6	254.7	305.6

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.